![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Tryton Medical Gains FDA Approval for Tryton Side Branch Stent
Tryton Medical Gains FDA Approval for Tryton Side Branch Stent
![](https://www.fdanews.com/ext/resources/test/Device_Images6/Tryton_Medical_company_logo.png?t=1488846244&width=430)
March 6, 2017
Tryton Medical has received FDA approval for the Tryton Side Branch Stent for the treatment of coronary bifurcation lesions involving large side branches.
The stent is intended for patients with large side branches — appropriate for a ≥2.5mm stent.
The stent is available in multiple diameters and is compatible with any conventional drug eluting stent in the main vessel. — Cynthia Jessup
Upcoming Events
-
21Oct